CD52 and neoplasm: Excluding the tissues that failed in the IHC staining analysis, the high expression of CD52 accounted for 46.8% (37/79) of tumor tissues, while 0% (0/88) of normal tissues (p < 0.001) (Supplementary Material-Table S1).